Pharmaceutical Contract Development and Manufacturing Market Worth $226.35 billion by 2029

Farma Darya

REDDING, Calif., May 19, 2022 /PRNewswire/ — According to a new market research report, “Pharmaceutical Contract Development and Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma, Generic] – Global Forecast to 2029,“ published by Meticulous Research®, the pharmaceutical contract development […]

The 2022 Society for Biomaterials, Technology Innovation and Development Award goes to Dr. Guillermo Ameer and the Acuitive Technologies Team

Farma Darya

The honor recognizes biomaterials research that significantly benefits patient health and outcomes ALLENDALE, N.J., May 9, 2022 /PRNewswire/ — It all started with a vision by Northwestern’s Dr. Guillermo A. Ameer, Daniel Hale Williams Professor of Biomedical Engineering at the McCormick School of Engineering and Surgery at the Feinberg School […]

Tribun Health is Entering the Pharmaceutical and Drug Development Market to Meet the Challenges of Precision Medicine

Farma Darya

The Tribun Health executive team is growing with the creation of a VP Pharma position to develop the expanding pharmaceutical business. Drug development Drug development PARIS, April 26, 2022 (GLOBE NEWSWIRE) — Tribun Health (Formerly Tribvn Healthcare) is pleased to announce the company’s expansion into the pharmaceutical market with the […]

CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers

Farma Darya

TEL AVIV, Israel and SEOUL, South Korea, April 12, 2022 /PRNewswire/ — CytoReason, a leading developer of computational disease models for efficient drug discovery and development, announced today the signing of a commercial partnership with Helixrus, a leading Korean company focused on biological big data and multi-omics. The partnership will […]